Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.18B | $2.09B | $2.24B | $2.00B | $2.08B | $1.91B | $2.02B | $1.82B |
| Cost of revenue | $635.50M | $576.20M | $792.40M | $559.30M | $592.20M | $549.80M | $586.70M | $538.60M |
| Gross profit | $1.54B | $1.51B | $1.45B | $1.44B | $1.49B | $1.36B | $1.44B | $1.29B |
| Gross margin | 70.8% | 72.4% | 64.7% | 72.1% | 71.5% | 71.2% | 71.0% | 70.5% |
| Research and development | $104.80M | $103.40M | $118.70M | $115.90M | $113.30M | $110.60M | $108.50M | $111.60M |
| Selling, general and administrative | $899.30M | $849.90M | $872.30M | $811.40M | $814.80M | $758.80M | $746.90M | $709.70M |
| Operating expenses | $1.22B | $1.14B | $1.30B | $1.09B | $1.19B | $1.07B | $1.05B | $1.01B |
| Operating income | $326.10M | $373.20M | $154.50M | $351.30M | $300.00M | $292.30M | $388.90M | $279.50M |
| Operating margin | 15.0% | 17.9% | 6.9% | 17.6% | 14.4% | 15.3% | 19.2% | 15.3% |
| EBITDA | $626.70M | $649.50M | $544.80M | $656.30M | $589.30M | $582.70M | $673.40M | $562.60M |
| Interest income | $0 | −$68.80M | $0 | — | $0 | −$66.20M | $0 | — |
| Interest expense | −$72.90M | $0 | −$71.90M | −$75.40M | −$79.30M | $0 | −$61.90M | −$54.30M |
| Income before taxes | $255.10M | $301.40M | $98.00M | $279.20M | $224.60M | $229.00M | $289.00M | $230.30M |
| Income taxes | $55.50M | $63.00M | −$39.90M | $48.00M | $71.20M | $46.50M | $48.90M | −$18.90M |
| Net income | $199.60M | $238.40M | $137.90M | $231.20M | $153.40M | $182.50M | $240.10M | $249.20M |
| Net margin | 9.2% | 11.4% | 6.1% | 11.6% | 7.4% | 9.6% | 11.9% | 13.7% |
| EPS, basic | $1.03 | $1.22 | $0.71 | $1.17 | $0.77 | $0.92 | $1.20 | $1.23 |
| EPS, diluted | $1.03 | $1.22 | $0.70 | $1.16 | $0.77 | $0.91 | $1.20 | $1.23 |
| Diluted shares | 192.80M | 195.80M | 198.00M | 198.80M | 198.30M | 199.70M | 200.00M | 203.00M |
Figures describe Zimmer Biomet shares, not any token. As of Aug 5, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.